Joseph W. Leach

7.6k total citations
55 papers, 1.4k citations indexed

About

Joseph W. Leach is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Joseph W. Leach has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Joseph W. Leach's work include Lung Cancer Research Studies (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Lung Cancer Treatments and Mutations (8 papers). Joseph W. Leach is often cited by papers focused on Lung Cancer Research Studies (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Lung Cancer Treatments and Mutations (8 papers). Joseph W. Leach collaborates with scholars based in United States, Belgium and Germany. Joseph W. Leach's co-authors include Karen K. Swenson, Mary Jo Nissen, John M. Truelson, Lynne I. Wagner, Janice Post‐White, Deborah Jean Lee Wong, James L. Gulley, Nicholas Iannotti, Arun Rajan and Arkadiusz Z. Dudek and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Joseph W. Leach

54 papers receiving 1.3k citations

Peers

Countries citing papers authored by Joseph W. Leach

Since Specialization

Citations

This map shows the geographic impact of Joseph W. Leach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph W. Leach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph W. Leach more than expected).

Fields of papers citing papers by Joseph W. Leach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph W. Leach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph W. Leach. The network helps show where Joseph W. Leach may publish in the future.

Co-authorship network of co-authors of Joseph W. Leach

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph W. Leach. A scholar is included among the top collaborators of Joseph W. Leach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph W. Leach. Joseph W. Leach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted eHealth Intervention to Reduce Breast Cancer Survivors’ Fear of Recurrence: Results From the FoRtitude Randomized Trial 2021 ·JNCI Journal of the National Cancer Institute ·Lynne I. Wagner, Janet A. Tooze, Daniel L. Hall, Beverly J. Levine, Jennifer L. Beaumont, Jennifer Duffecy, David Victorson, William J. Gradishar, Joseph W. Leach, Thomas J. Saphner, Keren Sturtz, Mary Lou Smith, Frank J. Penedo, David C. Mohr, David Cella	46
2	Clinicopathologic analysis of a large series of microinvasive breast cancers 2018 ·The Breast Journal ·Tamera J. Lillemoe, Michaela L. Tsai, Karen K. Swenson, (unknown), (unknown), Kendra Harris, Natasha M. Rueth, (unknown), Joseph W. Leach	15
3	Combination of nivolumab (nivo) + ipilimumab (ipi) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer (mCRC): CheckMate 142 Study 2017 ·Annals of Oncology ·Sara Lonardi, Thierry André, Ka Yeung Mark Wong, Michael A. Morse, Ray McDermott, Andrew Hill, Alain Hendlisz, Heinz‐Josef Lenz, Joseph W. Leach, Rebecca A. Moss, Z. Alexander Cao, Jean-Marie Ledeine, Scott Kopetz, Michael J. Overman	24
4	Safety of avelumab (MSB0010718C), an anti-PD-L1 antibody : updated analysis from the phase Ib JAVELIN solid tumor trial 2016 ·Open Repository and Bibliography (University of Liège) ·Karen Kelly, (unknown), J. R. Infante, Nicholas Iannotti, Petros Nikolinakos, Joseph W. Leach, (unknown), Jason C. Chandler, Guy Jérusalem, Jayne Gurtler, H-T. Arkenau, Marcis Bajars, Anja von Heydebreck, (unknown), (unknown), James L. Gulley	1
5	Nivolumab ± ipilimumab treatment (Tx) efficacy, safety, and biomarkers in patients (Pts) with metastatic colorectal cancer (mCRC) with and without high microsatellite instability (MSI-H): results from the CheckMate-142 study 2016 ·Annals of Oncology ·Michael J. Overman, Scott Kopetz, Sara Lonardi, Ray McDermott, Francesco Leone, Joseph W. Leach, Heinz‐Josef Lenz, Alain Hendlisz, Michael A. Morse, Pilar García‐Alfonso, Jayesh Desai, Andrew Hill, Rebecca A. Moss, Monica V. Goldberg, (unknown), Hao Tang, Thierry André	17
6	Phase 1/2 study of the safety and clinical activity of durvalumab in patients with non-small cell lung cancer (NSCLC) 2016 ·Annals of Oncology ·Scott Antonia, Julie R. Brahmer, Samir N. Khleif, Ani Sarkis Balmanoukian, S.-H.I. Ou, Martin Gutierrez, D.-W. Kim, (unknown), Myung‐Ju Ahn, Joseph W. Leach, (unknown), D. Jaeger, Guy Jérusalem, Jin Xiang, Amod Gupta, Joyce Antal, Neil H. Segal	32
7	Primary analysis from OAK, a randomized phase III study comparing atezolizumab with docetaxel in 2L/3L NSCLC 2016 ·Annals of Oncology ·Fabrice Barlési, K. Park, Fortunato Ciardiello, Joachim von Pawel, Shirish M. Gadgeel, Toyoaki Hida, Dariusz M. Kowalski, (unknown), Diego Cortinovis, Joseph W. Leach, Jonathan Polikoff, David R. Gandara, C.H. Barrios, (unknown), (unknown), Marcin Kowanetz, M. Ballinger, Daniel Waterkamp, A. Sandler, Achim Rittmeyer	56
8	A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer 2014 ·Gynecologic Oncology ·Ignace Vergote, Russell J. Schilder, Charles H. Pippitt, Shirley Wong, Alan N. Gordon, Sidney Scudder, Frédéric Kridelka, Luc Dirix, Joseph W. Leach, Sumitra Ananda, Nuwan Nanayakkara, (unknown), Michael Bass, Jason B. Litten, (unknown), Robert M. Wenham	15
9	Phase II Study of Topotecan and Bevacizumab in Advanced, Refractory Non–Small-Cell Lung Cancer 2013 ·Clinical Lung Cancer ·Steven Powell, Amer Beitinjaneh, Mathewos Tessema, Robin Bliss, Robert A. Kratzke, Joseph W. Leach, Arkadiusz Z. Dudek	18
10	Radon Testing and Mitigation: An Intervention in a Primary Care Setting 2012 ·Journal of Cancer Education ·Mary Jo Nissen, Joseph W. Leach, (unknown), Karen K. Swenson, (unknown)	17
11	Multicenter Phase II Trial of Motexafin Gadolinium and Pemetrexed for Second-Line Treatment in Patients with Non-small Cell Lung Cancer 2011 ·Journal of Thoracic Oncology ·Martin J. Edelman, Gregory A. Otterson, Joseph W. Leach, Thomas W. Malpass, Ravi Salgia, Dennie V. Jones, Tarak D. Mody, Ramaswamy Govindan	11
12	Preoperative Risk Assessment Among Women Undergoing Bilateral Prophylactic Mastectomy for Cancer Risk Reduction 2011 ·Annals of Surgical Oncology ·Natasha M. Rueth, Melissa McMahon, Amanda K. Arrington, Karen K. Swenson, Joseph W. Leach, Todd M. Tuttle	3
13	A Retrospective Study Evaluating Frequency and Risk Factors of Osteonecrosis of the Jaw in 576 Cancer Patients Receiving Intravenous Bisphosphonates 2011 ·American Journal of Clinical Oncology ·Vivek Thumbigere‐Math, (unknown), (unknown), Arkadiusz Z. Dudek, Scott Lunos, David L. Basi, Pamela Hughes, Joseph W. Leach, Karen K. Swenson, Rajaram Gopalakrishnan	74
14	Case-Control Study to Evaluate Predictors of Lymphedema After Breast Cancer Surgery 2009 ·Oncology nursing forum ·Karen K. Swenson, Mary Jo Nissen, Joseph W. Leach, Janice Post‐White	72
15	Bisphosphonate-Related Osteonecrosis of the Jaw: Clinical Features, Risk Factors, Management, and Treatment Outcomes of 26 Patients 2009 ·Journal of Oral and Maxillofacial Surgery ·Vivek Thumbigere‐Math, (unknown), Rajaram Gopalakrishnan, (unknown), Arkadiusz Z. Dudek, Saonli Basu, Pamela Hughes, Bryan S. Michalowicz, Joseph W. Leach, Karen K. Swenson, James Q. Swift, Cheryl Adkinson, David L. Basi	91
16	Correlation Between Intraoperative Hypothermia and Perioperative Morbidity in Patients With Head and Neck Cancer 2009 ·Archives of Otolaryngology - Head and Neck Surgery ·Baran D. Sumer, Larry L. Myers, Joseph W. Leach, John M. Truelson	31
17	Effects of exercise vs bisphosphonates on bone mineral density in breast cancer patients receiving chemotherapy. 2009 ·PubMed ·Karen K. Swenson, Mary Jo Nissen, (unknown), Alice Shapiro, (unknown), Joseph W. Leach	30
18	Interlocking Calvarial Bone Grafts: A Solution for the Short, Depressed Nose 2000 ·The Laryngoscope ·Joseph W. Leach	5
19	Acquired pure megakaryocytic aplasia report of two cases with long-term responses to antithymocyte globulin and cyclosporine 1999 ·American Journal of Hematology ·Joseph W. Leach, (unknown), James N. George	12
20	Traditional Methods vs Rigid Internal Fixation of Mandible Fractures 1995 ·Archives of Otolaryngology - Head and Neck Surgery ·Joseph W. Leach, John M. Truelson	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact